CureVac stand top IPO previous 12 months despite the delay of its vaccine against COVID-19, the next that should arrive in Europe.

Vaccine developers have been protagonists of the markets in recent months as part of the select group of values that have emerged in times of pandemic.

One of them is CureVac, the German biopharmaceutical firm that is already very close to launching its messenger RNA vaccine against COVID-19, and that has become one of the most important ipos of the year.

CureVac, in fact, was the IPO with the best performance of the last 12 months, showing a total return of 596.75%. The company, which specializes in mRNA technology, which is the basis of several leading coronavirus sera programs, debuted on the floor at $ 16 per share and shot up 249% on its first day, with the closing of $ 55.90.

According to Barron's, in January, CureVac reached an agreement with Bayer to accelerate the development and supply of its COVID-19 vaccine candidate, which is still in clinical trials, and whose 2b / 3 phase data is expected this summer. In this sense, since its stock market premiere its titles have doubled, flying over $ 111.48.

CureVac stand top IPO previous 12 months

But the success story, considering that the vaccine is not yet in circulation, may have only just begun.

Franz-Werner Haas, CEO of CureVac, explained in a recent interview collected by Bloomberg that the company's experimental vaccine can still play an important role in the fight against the pandemic given the “rapid spread” of some worrisome variants such as India or Vietnamese.

Franz-Werner Haas has commented that the injection his company, called CVnCoV, is already in the final stages of development and has benefited from the diverse range of variants of the virus, which are included in its trials. In this sense, the CEO of Curevac recalls that those new strains that emerged in recent months had displaced the original, which spread around the world last year.

CureVac stand top IPO previous 12 months

The European Medicines Agency, a European regulator, began an ongoing review of serum in February based on preliminary results from laboratory studies and early clinical studies in adults.

“In this environment rich in variations, we are convinced that our vaccine candidate against COVID-19, first generation, CVnCoV, will make an important contribution to the vaccination programs pandemic, for which the availability of vaccines powerful it is now more important than ever to avoid the virus continues to evolve,” said the head of the pharmaceutical.

"CVnCoV is in the final stage of clinical development in what we believe to be one of the most diverse efficacy trials in terms of the range of virus variants," Franz-Werner Haas said.

CureVac stand top IPO previous 12 months: Even though investors are eager to see the results, Bloomberg Intelligence analyst Sam Fazeli recently warned that none of the new vaccines are likely to be as effective as those that have already come out of Pfizer-BioNTech and Moderna.

Within the environment of vaccine development companies, investors are concerned that billions of dollars in sales will be compromised if the world opens the floodgates to manufacturing by other companies.

However, the actions regained some ground after Europe's less than unanimous acceptance of Biden's proposal. Moreover, analysts explained that, even with a patent exemption, other companies could not simply begin preparing batches of complex COVID-19 vaccines.

"Vaccine manufacturing is analogous to' space science 'in biological systems, and the mere temporary release of patents will have little effect on global manufacturing capacity," wrote Oppenheimer analyst Hartaj Singh, citing mRNA vaccines such as those of Moderna, BioNTech and Pfizer Inc, and CureVac

"What is probably needed is government support so that current manufacturers have more access to raw material supplies, rather than fragmenting them,” the expert said.

CureVac stand top IPO previous 12 months: Politics and logistics present another set of obstacles, Morgan Stanley analyst David Risinger wrote in a note. ” An exemption would have to be negotiated through the World Trade Organization, which could take months, and then the construction of the facilities would add to the delays, " he said.

Even though investors are eager to see the results, Bloomberg Intelligence analyst Sam Fazeli warned earlier this week that none of the newer vaccines are likely to be as effective as those that have already come out of Pfizer-BioNTech and Moderna.

However, the fall in the vaccine stock has not led analysts to hit the table and declare a buying opportunity, but it has brought some stock prices closer to what Wall Street considers a fair value. CureVac, for the moment, moves in those scales and, even so, it is one of the great stock trades of the year.

CureVac stand top IPO previous 12 months

More news:

How much money you should have saved at age 50, experts say

Getting into the culture of saving always has to go hand in hand with the advancement of the stages in your life. If you want to have a healthy personal finances and not have major problems, it is necessary yes or yes to adjust to a planning and a budget.

Throughout the phases that are crossed during the path of life it is necessary to have a stable personal economy, because it serves you to face with greater probability of success the goals that you have proposed. Hence, more and more people are interested in how much money should be saved with 50 years. Also, what are the most outstanding tips.

Given that the future of public pensions is increasingly in question, users are beginning to question their saving habits. The larger amounts set aside, the fewer problems will be experienced by the time the withdrawal arrives. Having good capital saved is vital, regardless of what you have set up for your emergency fund to deal with unforeseen situations.

Here it is very important to use applications that make it easier to save or adjust your budget by cutting certain expenses. They are strategies that are there and that you can throw away because, effectively, planning well is important.

Any method that is used and helps you is positive. Basically, to try to achieve the financial goals that you have previously set.

Therefore, this is where one of the main questions emerges, what is how much money you should have saved at 50 years to enjoy greater financial freedom and economic solvency.

For starters, you probably didn't know that time is related to the money you should have in store. It is a paradigm in the personal finance environment that is of enormous interest. Depending on the stage of life in which you are, according to your obligations and responsibilities, it is recommended to have a capital or other saved.

The savings has works in the long term with the aim of materializing all the proposals you have in mind. Also, to be able to solve any contingency or as a supplement to the public pension. What to do with the money saved is a decision to be made individually.

In this sense, to know the money saved that you should with respect to your age, you must start by knowing the net worth that you have, whose calculation is made by subtracting your assets from the liabilities. The result is the capital you have according to your age and income, but to prove it effectively there is some very useful formula.

One of them is the one developed by finance expert Kimmie Green. The basis is that at 30 years you would need to have a saving of one year of salary and every 5 years a multiplier would be added.

Therefore, following this procedure at the age of 45, someone should have saved the equivalent of 5 times their annual salary. This means that, if your annual salary is 20,000 euros, you should have saved 100,000 euros by the time you have reached that age.

Still, it's not the only reference you can attend to. In fact, they are not numbers that match what experts at BBVA estimate. In his view, those who receive salaries below 25,000 euros should already have a salary equivalent to 1.3 annual salaries at 40 years –about 1.6 at 50 years– that is between 35,000 and 40,000 euros.

Of course, those who exceed 60,000 should have already saved 300,000 euros, which would be equivalent to 5 salaries. In this way, it would depend on the annual remuneration that is earned.

It's not all numbers. Just don't ask yourself how much money you need at age 50, but what you can do to achieve those goals: formulas to save progressively and constantly. All this, without having to give up the daily comforts you currently have.

You can take as a reference many examples that can help you achieve that goal you have reached 50 years. One example would be to diversify investments with a long-term approach. It's an attractive option.

Also, try to automate your savings, don't spend more than you earn, or train as much as possible in financial culture.

However, one of the most interesting recommendations in this area is to consult with a financial advisor who can help you achieve the goals you have set with your wealth. There are many factors that determine that you can trust many of these professionals. Turning to one can make your financial path more clear of obstacles.